ABEONA THERAPEUTICS INC. (ABEO) Net margin 2016–2025
ABEONA THERAPEUTICS INC. (ABEO) net profit margin by fiscal year — reported net income divided by reported revenue.
1223.1%FY2025 · since FY2016: -2460.4% → 1223.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1223.1% | — |
| FY2023 | -1548.2% | +1259.1 pp |
| FY2022 | -2807.4% | +23.8 pp |
| FY2021 | -2831.2% | -1988.9 pp |
| FY2020 | -842.3% | — |
| FY2018 | -1890.3% | +1373.6 pp |
| FY2017 | -3263.9% | -803.5 pp |
| FY2016 | -2460.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABEO financial trends
ABEO RevenueABEO Net incomeABEO Gross profitABEO Gross marginABEO Operating incomeABEO Operating marginABEO Operating cash flowABEO Free cash flowABEO Capital expendituresABEO Return on equityABEO Stock buybacksABEO Dividends paidABEO Total assetsABEO Total liabilitiesABEO Shareholders’ equityABEO overview →